The University of Chicago Header Logo

Connection

Anjana Pillai to Bilirubin

This is a "connection" page, showing publications Anjana Pillai has written about Bilirubin.
Connection Strength

0.053
  1. Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study. Liver Int. 2023 03; 43(3):695-707.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.